department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Rystiggo · pharmadog

pharmadog
drugs
Rystiggo

drug

patient view →

rozanolixizumab

Marketedupdated 2mo ago

by UCB SA

Approved

community read0 votes

all catalysts(3)

approval · 3

RYSTIGGO (ROZANOLIXIZUMAB-NOLI) — FDA approval

rozanolixizumab

RYSTIGGO (ROZANOLIXIZUMAB-NOLI) — FDA approval

rozanolixizumab

RYSTIGGO (ROZANOLIXIZUMAB-NOLI) — FDA approval

rozanolixizumab

News(0)

no news has mentioned this drug yet

brand

Rystiggo

generic

rozanolixizumab-noli

indication

Myasthenia Gravis

phase

marketed

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

openFDA · ClinicalTrials.gov

last refreshed 25m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 3

tagApproval12 co-mentions · 3 sources
drugRYSTIGGO12 co-mentions · 3 sources
companyNew York University1 co-mentions · 1 sources

Trials studying rozanolixizumab

phase1A Study to Assess the Concentration of Rozanolixizumab in the Breast Milk of Healthy Lactating Womencompletedn=15
phase3A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravisrecruitingn=12
phase3An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravisenrolling by invitationn=12
phase4Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravisrecruitingn=40
phase3A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravisnot yet recruitingn=120
phase3A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)active not recruitingn=104
phase3A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravisnot yet recruitingn=100
phase3A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Graviscompletedn=200

more trials →